During the past decade, The Group for Women conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Group for Women" #1 sponsor was "Coloplast A/S" with 3 trials, followed by "Evofem Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Illumina, Inc." with 1 trials sponsored and "Inovio Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Group for Women" #1 collaborator was "Agility Clinical, Inc." with 1 trials as a collaborator and "Clinical Research Management, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "The Group for Women" are "Pregnancy" (2 trials), "Candida Vulvovaginitis" (1 trials), "Cervical Dysplasia" (1 trials), "Cervical High Grade Squamous Intraepithelial Lesion" (1 trials) and "Chlamydia" (1 trials). Many other conditions were trialed in "The Group for Women" in a lesser frequency.

Most popular intervention types in "The Group for Women" are "Device" (4 trials), "Drug" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "EVO100" (2 trials), "Altis® Single Incision Sling System (SIS)" (1 trials), "Electroporation (EP)" (1 trials) and "Ibrexafungerp" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Group for Women" are 10 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "The Group for Women". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in The Group for Women, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Group for Women, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".